Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Can Chipotle Mexican Grill, Inc. (CMG) Still Serve Up Spicy Growth in 2013?

Page 1 of 2

Chipotle Mexican Grill, Inc. (NYSE:CMG) is one of the most divisive stocks in the market. Value investors have always shied away from the stock, since it has traded at a hefty premium to the restaurant industry, while growth investors have relished in its strong return on investment over the past seven years.

Can Chipotle tackle slowing same-store sales, rising commodity costs, and increased competition, or will Chipotle’s growth get stunted by the same macro factors plaguing its industry rivals?

Chipotle Mexican Grill, Inc. (NYSE:CMG)Responsible, Sustainable Fast Food

Chipotle is a Mexican quick-serve restaurant that has carved out a niche for itself by only using organic, locally produced ingredients. Thanks to its positive image, the company is currently ranked third in consumer perception of fast food brands, trailing only Chick Fil-A and Panera Bread Co (NASDAQ:PNRA).

Fourth Quarter Fundamentals

For its fourth quarter, Chipotle’s earnings improved 7.7% to $1.95 per share, or $61.4 million, while revenue rose 17% to $699.2 million. Both top and bottom lines topped analyst estimates. However, same-store sales only rose 3.8%, missing the Thomson Reuters forecast of 3.9%.

That dip caused a lot of concern, but how did it fare compared to its industry peers during the fourth quarter?

Chipotle Qdoba Mexican Grill (Jack in the Box) Taco Bell (Yum) Panera Bread
+3.8% +0.4% +5% +5.1%

Source: Q4 Reports

It’s clear that Jack in the Box Inc. (NASDAQ:JACK)’s plans to take on Chipotle aren’t working out. However, Yum! Brands, Inc. (NYSE:YUM)’s more cheaply priced Taco Bell as well as the comparably priced Panera Bread both outpaced Chipotle’s growth.

Food Inflation

Chipotle, like its industry peers, is highly exposed to food inflation and rising commodity costs. During the fourth quarter, Chipotle’s restaurant-level operating margin slid from 26.1% to 24.6%, due to higher prices for meat, dairy products and salsa ingredients. Total food costs rose 22%, accounting for 34% of its total revenue.

To offset this threat, Chipotle intends to raise prices by 4% to 5% in the middle of fiscal 2013. Since Chipotle is considered ‘higher-end’ fast food, a price increase to preserve its margins could hurt its lagging same-store sales.

More importantly, Chipotle lacks a value or dollar menu, that McDonald’s Corporation (NYSE:MCD) and Yum! Brands, Inc. (NYSE:YUM) have been using to attract higher sales volume. Both McDonalds and Yum intend to boost advertising for their value menus in the second half of fiscal 2013.

Chipotle also lacks a comprehensive beverage menu, like McDonalds’ McCafe, which gives it more breathing room if certain food costs, such as grains, vegetables, or meat rise.

In this regard, Chipotle’s insistence on only using locally grown organic ingredients (within 350 miles) is a weakness. Chipotle’s competitors use factory farmed meat and imported vegetables and grains to maximize margins, although these practices are far less admirable.

To gain a better perspective on Chipotle’s margins, we should compare its operating margins over the past five years against its larger peers, which rely on industrial farming.

CMG Operating Margin TTM data by YCharts

Although Chipotle cannot match McDonald’s margins, it only underperforms Yum Brands by a hair.

That suggests that Chipotle can still maintain its operating margins while fighting the good fight by using locally grown organic products. However, does the company really have the pricing power to boost prices?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!